|
| |
 Andrew D. Luster MD PhD
Div Rheumatol, Allergy & Immunol
Massachusetts Gen Hosp
149 13th St, Rm 8303
Charlestown, MA 02129
luster@helix.mgh.harvard.edu
Biosketch:
Andrew
Luster is Chief of the Division of Rheumatology, Allergy and Immunology and
Director of the Center for Immunology and Inflammatory Diseases at Massachusetts
General Hospital and an Associate Professor of Medicine at
Harvard
Medical
School. He received his B.S. in 1981 from Duke University, his Ph.D. in
Molecular Genetics and Immunology in 1987 from Rockefeller University and his
M.D. in 1988 from Cornell University Medical College. He received his medical
training at Massachusetts General Hospital and his postdoctoral training at
Harvard Medical School.
Dr.
Luster’s laboratory studies the basic biology and pathobiology of
chemoattractants and their receptors, including chemokines and the lipid
mediator, leukotriene (LT) B4. Chemoattractants constitute a diverse
range of molecules that include proteins, peptide fragments and lipids that
control the movement of leukocytes in homeostasis and disease. These
molecularly distinct classes of chemoattractants all induce the directed
migration of cells by activating specific G protein-coupled seven transmembrane
spanning receptors expressed on various leukocyte subsets. Research in Dr.
Luster’s laboratory focuses on understanding the role of chemokines and lipid
chemoattractants and their chemoattractant receptors in controlling the
trafficking of leukocytes in vivo with a particular focus on their role
in mediating leukocyte trafficking in disease.
Presentation Title:
Chemokines and lipid mediators in inflammation.
Back to Molecular and
Cellular Basis of Disease:
New Developments in Inflammation
Back to Symposia
Back to Tuesday
|
